why choose us

First received: May 12, 2026

Clinical Trial: Tear Interleukin Biomarkers After Glaucoma Treatment

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Glaucoma

Study Type: INTERVENTIONAL


Official Title: Tear Fluid Interleukin Biomarkers and Intraocular Pressure Response After Micropulse Transscleral Cyclophotocoagulation, Conventional Cyclophotocoagulation, and Antiglaucoma Surgery in Patients With G

Brief Summary: This prospective study aims to evaluate inflammatory biomarkers in tear fluid in patients with glaucoma undergoing micropulse transscleral cyclophotocoagulation (MP-CPC), continuous-wave cyclophotocoagulation (CPC), and antiglaucoma surgeries. The study will assess the concentrations of pro- and anti-inflammatory interleukins in tear samples collected before treatment, 5-7 days after the procedure, and 1 month postoperatively.Intraocular pressure (IOP) will be measured at the same time points. The correlation…

Read more